News

Arelion Welcomes Gagun Gahir as EMEA Sales Leader

Arelion Welcomes Gagun Gahir as EMEA Sales Leader

Arelion Expands Leadership with New Enterprise Sales Director

Arelion has recently announced an exciting addition to its leadership team with the appointment of Gagun Gahir as the new Enterprise Sales Director for EMEA. This strategic move is aimed at bolstering the company's efforts to meet the growing demand for enterprise connectivity solutions across the region.

Driving Growth in Enterprise Connectivity

As businesses increasingly seek robust connectivity solutions, Arelion is poised to capitalize on significant global enterprise opportunities. Scott Nichols, the Chief Commercial Officer (CCO) at Arelion, expressed enthusiasm about this development, stating that Gagun's rich experience in the telecom sector positions the company well to address these rising demands.

Gagun Gahir's Background

With nearly two decades of leadership experience, Gahir boasts a diverse background in customer services, operations, and sales. Prior to joining Arelion, she was the Head of Enterprise Sales for Europe at Telstra, where she successfully led a team dedicated to expanding a robust portfolio of enterprise clients.

A Vision for Excellence

“Becoming the number one choice isn't just luck; it requires strategic efforts,” said Gagun Gahir. As the Enterprise Sales Director for EMEA, she sees Arelion as one of the best-kept secrets in telecommunications, dedicated to helping businesses maintain strong connections with clients and partners. Gahir emphasizes the importance of a collaborative approach and looks forward to building on the exceptional foundations laid by Arelion in the global telecommunications arena.

Commitment to Diversity and Inclusivity

Beyond her professional achievements, Gahir is a passionate advocate for equality in the telecommunications and technology sectors. Serving as an Empowered Ambassador with Capacity Media, she frequently speaks at major industry events to promote representation and inclusivity. Her dedication extends to being the chairperson for the Encephalitis International charity.

About Arelion's Services

Arelion plays a critical role in solving global connectivity challenges for multinational corporations that rely heavily on digital infrastructure. By utilizing the world’s top-ranked IP backbone, Arelion facilitates seamless internet services for clients in over 125 countries. The company connects customers with essential services, enabling low-latency connections that enhance operational efficiency.

Resilient Infrastructure and Services

Arelion's private Cloud Connect service directly connects to major cloud providers, including Amazon Web Services, Microsoft Azure, Google Cloud, IBM Cloud, and Oracle Cloud. With operations spanning continents, Arelion's solutions are designed to provide maximum reliability and performance, essential for today’s digital-first world.

Company Contacts

For those interested in learning more about Arelion's offerings or initiatives, Martin Sjögren, Senior Manager for PR and Analyst Relations, is available at +46 (0)707 770 522.

Frequently Asked Questions

Who is Gagun Gahir?

Gagun Gahir is the newly appointed Enterprise Sales Director for EMEA at Arelion, with extensive experience in the telecom sector.

What role will Gagun Gahir play at Arelion?

She will drive efforts to meet the increasing demand for enterprise connectivity solutions in the EMEA region.

What are Arelion's main services?

Arelion provides global connectivity solutions and supports multinational enterprises with a robust IP backbone and cloud services.

How does Arelion enhance connectivity?

They leverage direct connections to leading cloud service providers and offer low-latency internet services worldwide.

What initiatives does Gahun support?

Gunjung is an advocate for diversity and inclusion in technology, actively participating in various industry events and charitable work.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 11

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 9

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 14

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 20

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 21

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 10

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 19

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Sera Prognostics to Showcase Innovations at RBC Healthcare Event

Updated Category News Views 112

Sera Prognostics to Showcase Innovations at RBC Healthcare Event Sera Prognostics Inc., known as The Pregnancy Company (NASDAQ: SERA), is focused on enhancing maternal and neonatal health through innovative pregnancy biomarker information. The company has recently announced its participation at an important healthcare event, highlighting its ongoing commitment to improve...

Continue Reading
Unlocking AI Potential: Insights from Netcracker CEO Andrew Feinberg

Updated Category News Views 268

Exciting Keynote at GITEX Global 2024 Netcracker Technology is buzzing with excitement as Andrew Feinberg, the Chairman and CEO, prepares for a pivotal keynote presentation at one of the largest tech events in the world, GITEX Global 2024. This annual technology conference draws innovators, industry leaders, and enthusiasts keen on understanding the future of technology....

Continue Reading
Adherium Empowers COPD and Asthma Management with iCARE Study

Updated Category News Views 147

Adherium's Transformative iCARE Study Results The innovative strides made by Adherium Limited (ASX:ADR) in respiratory health have shown promising outcomes as seen in the iCARE study. This study investigated the effectiveness of their Hailie® Smartinhaler® technology in improving adherence among patients suffering from chronic obstructive pulmonary disease (COPD) and...

Continue Reading
Medius Highlights Impending Finance Challenges Post AI Launch

Updated Category News Views 243

AI Fraud Concerns Elevate in the Finance Sector Medius has unveiled alarming findings indicating that nearly one in three finance professionals are unable to spot AI-generated fake receipts. This revelation surfaces amidst rising fears of fraud escalation following the recent launch of GPT-5.0. With the capabilities of AI continuously improving, finance teams must prepare...

Continue Reading
TD Cowen Sustainably Endorses Abbott Labs with Robust Price Target

Updated Category News Views 59

TD Cowen Affirms Buy Rating on Abbott Laboratories TD Cowen has reaffirmed its Buy rating on Abbott Laboratories (NYSE: ABT), maintaining a price target of $130.00 for the healthcare company's shares. This positive stance hinges on expectations that Abbott's upcoming third-quarter results will either meet or surpass current market predictions, allowing the company to...

Continue Reading